Literature DB >> 19864431

Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation.

Kathryn G Foster1, Hugo A Acosta-Jaquez, Yves Romeo, Bilgen Ekim, Ghada A Soliman, Audrey Carriere, Philippe P Roux, Bryan A Ballif, Diane C Fingar.   

Abstract

The rapamycin-sensitive mTOR complex 1 (mTORC1) promotes protein synthesis, cell growth, and cell proliferation in response to growth factors and nutritional cues. To elucidate the poorly defined mechanisms underlying mTORC1 regulation, we have studied the phosphorylation of raptor, an mTOR-interacting partner. We have identified six raptor phosphorylation sites that lie in two centrally localized clusters (cluster 1, Ser(696)/Thr(706) and cluster 2, Ser(855)/Ser(859)/Ser(863)/Ser(877)) using tandem mass spectrometry and generated phosphospecific antibodies for each of these sites. Here we focus primarily although not exclusively on raptor Ser(863) phosphorylation. We report that insulin promotes mTORC1-associated phosphorylation of raptor Ser(863) via the canonical PI3K/TSC/Rheb pathway in a rapamycin-sensitive manner. mTORC1 activation by other stimuli (e.g. amino acids, epidermal growth factor/MAPK signaling, and cellular energy) also promote raptor Ser(863) phosphorylation. Rheb overexpression increases phosphorylation on raptor Ser(863) as well as on the five other identified sites (e.g. Ser(859), Ser(855), Ser(877), Ser(696), and Thr(706)). Strikingly, raptor Ser(863) phosphorylation is absolutely required for raptor Ser(859) and Ser(855) phosphorylation. These data suggest that mTORC1 activation leads to raptor multisite phosphorylation and that raptor Ser(863) phosphorylation functions as a master biochemical switch that modulates hierarchical raptor phosphorylation (e.g. on Ser(859) and Ser(855)). Importantly, mTORC1 containing phosphorylation site-defective raptor exhibits reduced in vitro kinase activity toward the substrate 4EBP1, with a multisite raptor 6A mutant more strongly defective that single-site raptor S863A. Taken together, these data suggest that complex raptor phosphorylation functions as a biochemical rheostat that modulates mTORC1 signaling in accordance with environmental cues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19864431      PMCID: PMC2804229          DOI: 10.1074/jbc.M109.029637

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  73 in total

1.  GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR.

Authors:  Do-Hyung Kim; D D Sarbassov; Siraj M Ali; Robert R Latek; Kalyani V P Guntur; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

2.  Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.

Authors:  Robbie Loewith; Estela Jacinto; Stephan Wullschleger; Anja Lorberg; José L Crespo; Débora Bonenfant; Wolfgang Oppliger; Paul Jenoe; Michael N Hall
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

3.  Two motifs in the translational repressor PHAS-I required for efficient phosphorylation by mammalian target of rapamycin and for recognition by raptor.

Authors:  Kin Man Choi; Lloyd P McMahon; John C Lawrence
Journal:  J Biol Chem       Date:  2003-03-28       Impact factor: 5.157

4.  The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif.

Authors:  Hiroki Nojima; Chiharu Tokunaga; Satoshi Eguchi; Noriko Oshiro; Sujuti Hidayat; Ken-ichi Yoshino; Kenta Hara; Noriaki Tanaka; Joseph Avruch; Kazuyoshi Yonezawa
Journal:  J Biol Chem       Date:  2003-02-25       Impact factor: 5.157

5.  TSC2 mediates cellular energy response to control cell growth and survival.

Authors:  Ken Inoki; Tianqing Zhu; Kun-Liang Guan
Journal:  Cell       Date:  2003-11-26       Impact factor: 41.582

6.  Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin.

Authors:  Andrew R Tee; Rana Anjum; John Blenis
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

7.  mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E.

Authors:  Diane C Fingar; Celeste J Richardson; Andrew R Tee; Lynn Cheatham; Christina Tsou; John Blenis
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

8.  TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function.

Authors:  Stefanie S Schalm; Diane C Fingar; David M Sabatini; John Blenis
Journal:  Curr Biol       Date:  2003-05-13       Impact factor: 10.834

Review 9.  Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression.

Authors:  Diane C Fingar; John Blenis
Journal:  Oncogene       Date:  2004-04-19       Impact factor: 9.867

10.  Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.

Authors:  Andrew R Tee; Diane C Fingar; Brendan D Manning; David J Kwiatkowski; Lewis C Cantley; John Blenis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

View more
  84 in total

1.  ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1).

Authors:  Audrey Carriere; Yves Romeo; Hugo A Acosta-Jaquez; Julie Moreau; Eric Bonneil; Pierre Thibault; Diane C Fingar; Philippe P Roux
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

2.  The Glial Cell-Derived Neurotrophic Factor (GDNF)-responsive Phosphoprotein Landscape Identifies Raptor Phosphorylation Required for Spermatogonial Progenitor Cell Proliferation.

Authors:  Min Wang; Yueshuai Guo; Mei Wang; Tao Zhou; Yuanyuan Xue; Guihua Du; Xiang Wei; Jing Wang; Lin Qi; Hao Zhang; Lufan Li; Lan Ye; Xuejiang Guo; Xin Wu
Journal:  Mol Cell Proteomics       Date:  2017-04-13       Impact factor: 5.911

3.  Phosphorylation of Raptor by p38beta participates in arsenite-induced mammalian target of rapamycin complex 1 (mTORC1) activation.

Authors:  Xiao-Nan Wu; Xue-Kun Wang; Su-Qin Wu; Jiawei Lu; Min Zheng; Yan-Hai Wang; Huamin Zhou; Hongbing Zhang; Jiahuai Han
Journal:  J Biol Chem       Date:  2011-07-14       Impact factor: 5.157

4.  Functional Proteomics Identifies Acinus L as a Direct Insulin- and Amino Acid-Dependent Mammalian Target of Rapamycin Complex 1 (mTORC1) Substrate.

Authors:  Jennifer Jasmin Schwarz; Heike Wiese; Regine Charlotte Tölle; Mostafa Zarei; Jörn Dengjel; Bettina Warscheid; Kathrin Thedieck
Journal:  Mol Cell Proteomics       Date:  2015-04-23       Impact factor: 5.911

Review 5.  Regulation of mTORC1 by PI3K signaling.

Authors:  Christian C Dibble; Lewis C Cantley
Journal:  Trends Cell Biol       Date:  2015-07-06       Impact factor: 20.808

6.  Control of mTORC1 signaling by the Opitz syndrome protein MID1.

Authors:  Enbo Liu; Christine A Knutzen; Sybille Krauss; Susann Schweiger; Gary G Chiang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

7.  Aspirin may inhibit angiogenesis and induce autophagy by inhibiting mTOR signaling pathway in murine hepatocarcinoma and sarcoma models.

Authors:  Qianqian Zhao; Zhaopeng Wang; Zhaoxia Wang; Licun Wu; Weidong Zhang
Journal:  Oncol Lett       Date:  2016-08-16       Impact factor: 2.967

Review 8.  TOR-dependent control of autophagy: biting the hand that feeds.

Authors:  Thomas P Neufeld
Journal:  Curr Opin Cell Biol       Date:  2009-12-16       Impact factor: 8.382

9.  The human kinome and kinase inhibition.

Authors:  Krisna C Duong-Ly; Jeffrey R Peterson
Journal:  Curr Protoc Pharmacol       Date:  2013-03

10.  Human phospholipase D activity transiently regulates pyrimidine biosynthesis in malignant gliomas.

Authors:  Thomas P Mathews; Salisha Hill; Kristie L Rose; Pavlina T Ivanova; Craig W Lindsley; H Alex Brown
Journal:  ACS Chem Biol       Date:  2015-02-17       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.